Skip to main content
Ind-Swift Laboratories Ltd. logo

Ind-Swift Laboratories Ltd. — Investor Relations & Filings

Ticker · INDSWFTLAB ISIN · INE915B01019 LEI · 335800ZT8UFD9Y8ZMP56 BSE.NS Manufacturing
Open in API
Filings indexed 809 across all filing types
Latest filing 2026-03-27 Board/Management Inform…
Country IN India
Listing BSE.NS INDSWFTLAB

About Ind-Swift Laboratories Ltd.

https://www.indswiftlabs.com

Ind-Swift Laboratories Ltd. is a global manufacturer specializing in Active Pharmaceutical Ingredients (APIs) and Advanced Intermediates. The company focuses on research and development, process chemistry, and large-scale production across diverse therapeutic segments, including macrolide antibiotics, cardiovascular agents, antihistamines, antidiabetics, and antipsychotics. Operating multiple manufacturing facilities that adhere to international regulatory standards such as USFDA, EDQM, and PMDA, the organization provides high-quality chemical entities to the global market. Its core competencies lie in complex chemical synthesis and the development of cost-effective manufacturing processes for generic and specialty drug substances. The company maintains a strong emphasis on quality assurance and regulatory compliance to support its extensive portfolio of products distributed worldwide.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Board/Management Information Classification · 95% confidence The document is a formal announcement from the company IND-SWIFT LABORATORIES LTD. regarding the outcome of a Board Meeting held on March 27, 2026. The key content includes the appointment of M/s. Jain & Associates as Internal Auditors for the financial year 2026-27 and approval of a Postal Ballot Notice. The document references compliance with SEBI Listing Regulations and provides details under Regulation 30, which pertains to disclosures about changes in company management or appointments. The document is short (3525 characters) and primarily serves as an announcement of a board decision rather than a detailed report or financial statement. It does not contain financial data, audit results, or detailed management discussion. Therefore, it fits best under the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management, including appointments of auditors as part of governance disclosures.
2026-03-27 English
General Updates
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing about the company receiving the EcoVadis Silver Medal and other global certifications related to sustainability and ESG performance. It is a regulatory announcement informing the stock exchanges and public about an achievement and certifications, not a detailed report or financial statement. The document does not contain financial data, earnings, or management discussion of financial results. It is a compliance and regulatory disclosure about ESG recognition and certifications. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-03-02 English
Disclosure of material issue
Capital/Financing Update Classification · 95% confidence The document is an official intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about the lapse of 6,500,000 fully convertible warrants and forfeiture of the upfront amount. The document references regulatory compliance and provides details about the warrants, their allotment, lapse, and forfeiture. It is a notification about a capital structure event related to warrants but does not contain financial statements or detailed financial analysis. The document length is 3,732 characters, which is relatively short and focused on a specific event. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes. It is not an announcement of a report publication, nor a full financial report, nor a regulatory filing of a different nature. Therefore, the correct classification is CAP with high confidence.
2026-03-01 English
General Updates
Regulatory Filings
2026-02-27 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to stock exchanges (BSE and NSE) about the schedule of upcoming meetings with analysts and institutional investors. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and explicitly states that no unpublished price sensitive information will be shared. The content is an announcement of scheduled investor meetings rather than a report or transcript of the meetings themselves. It does not contain financial data, earnings, or detailed presentations. The document length is short (2004 characters), and it serves as an informational notice about investor meetings. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-02-26 English
Conversion
Capital/Financing Update Classification · 95% confidence The document is an official communication addressed to stock exchanges (BSE and NSE) regarding the outcome of a Preferential Issue Committee meeting of the Board of Directors. It details the allotment of equity shares pursuant to the conversion of fully convertible warrants, including specifics such as the number of shares allotted, the issue price, and the resulting increase in paid-up share capital. The document references compliance with SEBI regulations and includes an annexure with detailed disclosures about the preferential allotment. The content is focused on a capital structure change through preferential allotment and share issuance, not a full financial report or earnings release. The document length is 4536 characters, which is sufficient to contain substantive information rather than just an announcement. Therefore, this fits the category of a Capital/Financing Update (CAP) as it reports on fundraising and capital structure changes via preferential allotment of shares.
2026-02-24 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.